News

Brett Arends’s ROI: Daniel Craig doesn’t plan to leave much money to his kids when he dies

0
Panorama of a city business district with office buildings and skyscrapers and superimposed data, charts and diagrams related to stock market, currency exchange and global finance. Blue line graphs with numbers and exchange rates, candlestick charts and financial figures fill the image with a glowing light. Sunset light.

‎Now Daniel Craig’s children know how the rest of us feel when contemplating his legacy.

Disappointed.

The James Bond actor, allegedly banking $25 million to resume the role yet again, has told Candis magazine in his native Great Britain that he doesn’t plan to leave much of his fortune to his two children.

“My philosophy is to get rid of it or give it away before you go,” Craig told the magazine. He cited an adage that “if you die a rich person you’ve failed,” calling it “distasteful” to leave massive sums to your heirs.

If you are the child of one of the world’s highest paid actors, this is the financial equivalent of starting with Casino Royale, arguably the greatest Bond movie ever made, and then ending up with Skyfall and Spectre, which your correspondent considers the two worst.

Maybe his kids knew this all along. So maybe they didn’t have their high hopes dashed.

Craig is not alone among the wealthy in saying he doesn’t plan to leave his fortune to his kids. Billionaires Warren Buffett and Bill Gates have said much the same. On the other hand, everything is relative. Most people would considers themselves lucky even to leave, say, a few hundred thousand dollars each to their kids. What you leave after the first million or two is moot.

It’s been wisely argued that leaving your children enough money so they can do anything is much better for them than leaving them enough money so they can do nothing.

Tax Guy: What to know about paying taxes on mutual fund gains — and the SEC rule that can help investors choose between competing funds

Previous article

Coronavirus Update: FDA approves BioNTech and Pfizer’s COVID-19 shot, making it the first vaccine to receive ‘full’ approval in the U.S.

Next article

You may also like

Comments

Leave a reply

Your email address will not be published. Required fields are marked *

More in News